Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/04/2003US20030165535 Gag protein genes; reduced sensitivity
09/04/2003US20030165528 Streptococcus pyogenes antigens
09/04/2003US20030165520 Attenuated forms of bovine viral diarrhea virus
09/04/2003US20030165516 Cytotoxic lumphocyte response; genetic engineering mutants
09/04/2003US20030165515 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/04/2003US20030165512 Composition of antigen and glycolipid adjuvant for sublingual administration
09/04/2003US20030165511 Protein-virus Complex; culture product; viricides
09/04/2003US20030165507 Postexposure prophylaxis therapy
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165478 Stabilized synthetic immunogen delivery system
09/04/2003US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents
09/04/2003US20030165434 Delivery of polynucleotide agents to the central nervous system
09/04/2003CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus
09/04/2003CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003CA2477741A1 Nucleotide mimics and their prodrugs
09/04/2003CA2477417A1 Methods and products based on oligomerization of stress proteins
09/04/2003CA2477379A1 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
09/04/2003CA2477344A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
09/04/2003CA2477287A1 Uracil-thioether
09/04/2003CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
09/04/2003CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/04/2003CA2477224A1 Piperidine ouracil used as a medicament for treating bacterial infections
09/04/2003CA2477170A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003CA2477105A1 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
09/04/2003CA2477049A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
09/04/2003CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003CA2476666A1 Haemophilus adherence and penetration proteins
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2476571A1 Method for isolating ligands
09/04/2003CA2476038A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/04/2003CA2467833A1 Pharmaceutical compositions in particulate form
09/04/2003CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity
09/03/2003EP1340757A1 1-methylcarbapenem derivatives
09/03/2003EP1340756A1 Novel beta-lactam compounds and proecss for producing the same
09/03/2003EP1340755A1 Anti-helicobacterial agents
09/03/2003EP1340750A1 Amide derivatives
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1340495A1 Extended release formulations of erythromycin derivatives
09/03/2003EP1340086A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample
09/03/2003EP1340079A2 S. aureus protein staau-r2, gene encoding it and uses thereof
09/03/2003EP1339878A2 Method for identifying modulators of transcription
09/03/2003EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol
09/03/2003EP1339753A2 Percarboxylated polysaccharides, and a process for their preparation
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339738A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/03/2003EP1339730A2 Macrolide solvates
09/03/2003EP1339725A2 Dna methyl transferase inhibitors
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339692A1 Novel compounds for use as hiv protease inhibitors
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/03/2003EP1339502A1 Method for producing a partial or complete active ingredient coating on and in implants and onplants
09/03/2003EP1339427A2 Method of producing biospecific molecules by protein trans-splicing
09/03/2003EP1339420A1 Process for preparing aqueous extracts of plants and extracts so obtained
09/03/2003EP1339415A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
09/03/2003EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines
09/03/2003EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1339400A1 Hydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections
09/03/2003EP1339386A2 Reversible gelling system for ocular drug delivery
09/03/2003EP1339373A1 Use of moulding compounds for producing treatment devices
09/03/2003EP1233794B1 A bioabsorbable drug delivery system
09/03/2003EP1214300B1 Rate-controlled particles
09/03/2003EP1185237B1 Synergistic antibacterial combination
09/03/2003EP1140952B1 Organo-phosphorus compounds and their utilization
09/03/2003EP1140048B1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
09/03/2003EP1090014B1 Arylsulfonanilide phosphates
09/03/2003EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives
09/03/2003EP0948332B1 Antiherpetic medicated stick containing acyclovir for topical application
09/03/2003EP0941229B1 Purification of fermented clavulanic acid
09/03/2003EP0929533B1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
09/03/2003EP0925070B1 Antifungal combination therapy
09/03/2003EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4
09/03/2003EP0833645B1 Antiviral agents
09/03/2003EP0773030B1 Method of purifying necrotoxin produced by bordetella
09/03/2003EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
09/03/2003EP0651646B1 Therapeutic conjugates of toxins and drugs
09/03/2003CN1440462A Method of identifying and producing antigen peptides and use thereof as vaccines
09/03/2003CN1440459A Expression system
09/03/2003CN1440456A Sentinel virus Ôàí"
09/03/2003CN1440423A Immunoadhesin for the prevention of rhinovirus infection
09/03/2003CN1440419A Compounds and methods for treatment and prevention of bacterial infection
09/03/2003CN1440414A Synthesis of cuttlefish compound
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
09/03/2003CN1440404A Benzofuran derivatives and their use as antibacterial agents
09/03/2003CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/03/2003CN1440385A Pyrrole derivatives for treating AIDS
09/03/2003CN1440296A Vaccine against foot-and-mouth disease
1 ... 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 ... 1798